T
CLPT icon

Tidemark’s ClearPoint Neuro CLPT Stock Holding History

Tidemark’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.8K Hold
832
– – ﹤0.01% 457
2026
Q1 		$7.57K Hold
832
– – ﹤0.01% 496
2025
Q4 		$11.4K Hold
832
– – ﹤0.01% 416
2025
Q3 		$18.1K Hold
832
– – 0.01% 377
2025
Q2 		$9.93K Sell
832
-232
-22% -$2.92K ﹤0.01% 451
2025
Q1 		$12.7K Buy
+1,064
New +$16.5K ﹤0.01% 402

Other funds holding CLPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
CFM
Compass Financial Management Tampa, Florida $829M AUM

Tidemark's CLPT Position: Q2 2026 in Review

Tidemark held its ClearPoint Neuro (CLPT) position steady in Q2 2026 at 832 shares worth $14.8K. The position accounts for ﹤0.01% of the portfolio, ranked #457.

Tidemark first reported a position in CLPT in Q1 2025 and has held it in 6 quarters since. The position peaked at $18.1K in Q3 2025. 129 funds tracked by Wall St. Rank hold CLPT as of Q2 2026.

  • Tidemark held 832 shares of ClearPoint Neuro worth $14.8K as of Q2 2026.
  • Tidemark left its ClearPoint Neuro share count unchanged in Q2 2026.
  • ClearPoint Neuro made up ﹤0.01% of Tidemark's portfolio in Q2 2026, its #457 holding.
  • Tidemark first reported a position in ClearPoint Neuro in Q1 2025 and has held it in 6 quarters since.
  • Tidemark's ClearPoint Neuro position peaked at $18.1K in Q3 2025.
  • 129 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q2 2026.

Based on Tidemark's 13F filing for Q2 2026, filed 10 Aug 2026.